உட்டா புற்றுநோய் பதிவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உட்டா புற்றுநோய் பதிவு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உட்டா புற்றுநோய் பதிவு Today - Breaking & Trending Today

Colon cancer risk extends to second- and third-degree relatives - UB Now: News and views for UB faculty and staff

Having Second- or Third-Degree Relatives With Colorectal Cancer Increases a Person's Risk of Disease

Cancer News from AACR's 2021 Meeting: Targeted Therapy and Immunotherapy


Canva; Everyday Health
The annual meeting of the American Association for Cancer Research (AACR) is one of the largest cancer research meetings of its kind, bringing together a range of researchers, from those who spend their time in the lab to those who focus on patients in the clinic. The meeting atmosphere is electric even when it’s virtual. Here are five key studies that stood out during the first week of the virtual AACR meeting, held April 10–15, 2021.
Lymphoma Progression Cut in Half When Rituxan Is Paired With Aliqopa
What’s new Patients with relapsed indolent non-Hodgkin lymphoma saw a 48 percent reduced risk of progression (time without the disease advancing or death) when the targeted therapy Aliqopa (copanlisib) was used in combination with Rituxan (rituximab) versus Rituxan alone. Rituxan alone is the current standard therapy for relapses. The results, which come from a phase 3 trial known as CHRONOS-3, were announced at the AACR meeting and simu ....

New York , United States , Salt Lake City , Memorial Sloan Kettering Cancer Center , University Of Utah , Matthewj Matasar , Jessica Hassel , Aliqopa Rituxan , Patrick Forde , Anna Plym , American Association For Cancer Research , Huntsman Cancer Institute , Sidney Kimmel Comprehensive Cancer Center , Lymphoma Society , American Association , Cancer Research , Progression Cut , How Is Hodgkin Lymphoma , Punch Against Earlier Stage Lung , Bloomberg Kimmel Institute , Johns Hopkins University , Why Are , Never Smoker Getting Lung , Super Glue Protein Allows Immune System , Amp Up Response , Metastatic Ocular ,